Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.

MLA

Mahjoub, Mohammad Amin, et al. “Combination Treatment with Dendrosomal Nanocurcumin and Doxorubicin Improves Anticancer Effects on Breast Cancer Cells through Modulating CXCR4/NF-ΚB/Smo Regulatory Network.” Molecular Biology Reports, vol. 44, no. 4, Aug. 2017, pp. 341–51. EBSCOhost, https://doi.org/10.1007/s11033-017-4115-2.

APA

Mahjoub, M. A., Bakhshinejad, B., Sadeghizadeh, M., & Babashah, S. (2017). Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network. Molecular Biology Reports, 44(4), 341–351. https://doi.org/10.1007/s11033-017-4115-2

Chicago

Mahjoub, Mohammad Amin, Babak Bakhshinejad, Majid Sadeghizadeh, and Sadegh Babashah. 2017. “Combination Treatment with Dendrosomal Nanocurcumin and Doxorubicin Improves Anticancer Effects on Breast Cancer Cells through Modulating CXCR4/NF-ΚB/Smo Regulatory Network.” Molecular Biology Reports 44 (4): 341–51. doi:10.1007/s11033-017-4115-2.